UK markets closed

NeueHealth, Inc. (NEUE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.03-0.39 (-6.07%)
As of 12:16PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 52.80M
Enterprise value 1.25B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.04
Price/book (mrq)N/A
Enterprise value/revenue 1.08
Enterprise value/EBITDA -2.21

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-62.50%
S&P500 52-week change 325.59%
52-week high 326.96
52-week low 34.94
50-day moving average 36.77
200-day moving average 38.01

Share statistics

Avg vol (3-month) 311.78k
Avg vol (10-day) 35.22k
Shares outstanding 58.22M
Implied shares outstanding 68.22M
Float 83.35M
% held by insiders 15.48%
% held by institutions 163.61%
Shares short (15 Apr 2024) 442.2k
Short ratio (15 Apr 2024) 44.22
Short % of float (15 Apr 2024) 42.44%
Short % of shares outstanding (15 Apr 2024) 40.51%
Shares short (prior month 15 Mar 2024) 440.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:80
Last split date 322 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -99.19%
Operating margin (ttm)-15.64%

Management effectiveness

Return on assets (ttm)-3.58%
Return on equity (ttm)-183.26%

Income statement

Revenue (ttm)1.16B
Revenue per share (ttm)145.94
Quarterly revenue growth (yoy)28.60%
Gross profit (ttm)N/A
EBITDA -144.45M
Net income avi to common (ttm)-562.53M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)93.56M
Total cash per share (mrq)11.66
Total debt (mrq)399.87M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.78
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-2.73B
Levered free cash flow (ttm)27.03M